Group One Trading’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Buy |
+8,239
| New | +$23.9K | ﹤0.01% | 1417 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2955 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2996 |
|
|
2024
Q1 | – | Sell |
-4,590
| Closed | -$6.75K | – | 3086 |
|
|
2023
Q4 | $6.75K | Sell |
4,590
-29,600
| -87% | -$43.5K | ﹤0.01% | 1478 |
|
|
2023
Q3 | $41.4K | Sell |
34,190
-57,780
| -63% | -$69.9K | ﹤0.01% | 1126 |
|
|
2023
Q2 | $133K | Buy |
91,970
+4,866
| +6% | +$7.06K | ﹤0.01% | 793 |
|
|
2023
Q1 | $126K | Buy |
87,104
+81,363
| +1,417% | +$118K | ﹤0.01% | 787 |
|
|
2022
Q4 | $9.93K | Sell |
5,741
-49,359
| -90% | -$85.4K | ﹤0.01% | 1448 |
|
|
2022
Q3 | $110K | Buy |
55,100
+30,856
| +127% | +$61.6K | ﹤0.01% | 991 |
|
|
2022
Q2 | $18K | Buy |
+24,244
| New | +$18K | ﹤0.01% | 1528 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3140 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3195 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3085 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2968 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2775 |
|
|
2020
Q4 | – | Sell |
-4,548
| Closed | -$51K | – | 2499 |
|
|
2020
Q3 | $51K | Buy |
4,548
+1,500
| +49% | +$16.8K | ﹤0.01% | 1073 |
|
|
2020
Q2 | $41K | Buy |
+3,048
| New | +$41K | ﹤0.01% | 963 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$1K | – | 2098 |
|
|
2019
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 1176 |
|
|
2019
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 1160 |
|
|
2018
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1312 |
|